Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 12, 1988 - Issue 5-6
26
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Selection of Hydroxypyridin-4-Ones for the Treatment of Iron Overload Using In Vitro and In Vivo Models

, &
Pages 593-600 | Received 22 Dec 1987, Accepted 01 Jun 1988, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

MarkM. Jones. (1992) Newer Chelating Agents for in Vivo Toxic Metal Mobilization. Comments on Inorganic Chemistry 13:2, pages 91-110.
Read now
MarkM. Jones. (1991) The Design of Therapeutic Chelating Agents. Journal of Coordination Chemistry 23:1-4, pages 187-200.
Read now
Mark M. Jones. (1991) New Developments in Therapeutic Chelating Agents as Antidotes for Metal Poisoning. Critical Reviews in Toxicology 21:3, pages 209-233.
Read now

Articles from other publishers (23)

George J. Kontoghiorghes. (2023) Deferiprone and Iron–Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects. International Journal of Molecular Sciences 24:5, pages 4970.
Crossref
Shailza Sharma, Minati Baral & B. K. Kanungo. (2022) Recent advances in therapeutical applications of the versatile hydroxypyridinone chelators. Journal of Inclusion Phenomena and Macrocyclic Chemistry 102:3-4, pages 169-200.
Crossref
Samie Salehi, Amir Shokooh Saljooghi & Mohammad Izadyar. (2016) A theoretical study on the electronic structures and equilibrium constants evaluation of Deferasirox iron complexes. Computational Biology and Chemistry 64, pages 99-106.
Crossref
Yu-Lin Chen, Dave J. Barlow, Xiao-Le Kong, Yong-Min Ma & Robert C. Hider. (2012) Prediction of 3-hydroxypyridin-4-one (HPO) log K1 values for Fe(iii). Dalton Transactions 41:35, pages 10784.
Crossref
Yu-Lin Chen, Dave J. Barlow, Xiao-Le Kong, Yong-Min Ma & Robert C. Hider. (2012) Prediction of 3-hydroxypyridin-4-one (HPO) hydroxyl pKa values. Dalton Transactions 41:21, pages 6549.
Crossref
John Burgess & Maria Rangel. 2008. 167 243 .
A.E.R. Kartikasari, N.A. Georgiou & J.J.M. Marx. 2004. Functional Foods, Cardiovascular Disease and Diabetes. Functional Foods, Cardiovascular Disease and Diabetes 99 125 .
Arthur E Martell, R.J Motekaitis, Y Sun, R Ma, M.J Welch & T Pajeau. (1999) New chelating agents suitable for the treatment of iron overload. Inorganica Chimica Acta 291:1-2, pages 238-246.
Crossref
Paul Baret, Virginie Beaujolais, Claude Béguin, Didier Gaude, Jean-Louis Pierre & Guy Serratrice. (1998) Towards New Iron(III) Chelators: Synthesis and Complexing Ability of a Water-Soluble Tripodal Ligand Based on 2,2′-Dihydroxybiphenyl Subunits. European Journal of Inorganic Chemistry 1998:5, pages 613-619.
Crossref
Arthur E. Martell & Robert D. HancockArthur E. Martell & Robert D. Hancock. 1996. Metal Complexes in Aqueous Solutions. Metal Complexes in Aqueous Solutions 149 197 .
D. M. Templeton. 1995. Toxicology of Metals. Toxicology of Metals 305 331 .
Chaim Hershko. (1994) 11 Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators. Baillière's Clinical Haematology 7:4, pages 965-1000.
Crossref
Christopher D. Saudek & Samuel Charache. (1992) 5 Haemochromatosis and diabetes. Baillière's Clinical Endocrinology and Metabolism 6:4, pages 807-817.
Crossref
C. Hershko, V.R. Gordeuk, G.M. Brittenham, P.E. Thuma, E.N. Theanacho, D.T. Spira, R.C. Hider & T.E.A. Peto. (1992) The antimalarial effect of iron chelators: Studies in animal models and in humans with mild falciparum malaria. Journal of Inorganic Biochemistry 47:1, pages 267-277.
Crossref
Gaoyi Xiao, Dick van der Helm, Robert C. Hider & Paul S. Dobbin. (1992) Structure–stability relationships of 3-hydroxypyridin-4-one complexes. J. Chem. Soc., Dalton Trans.:22, pages 3265-3271.
Crossref
John M. Skjaerlund, Gary S. Krause, Deborah M. Feldman, Brian J. O'Neil & Blaine C. White. (1991) The effect of EMHP on post-cardiac arrest survival of rats. Resuscitation 22:2, pages 139-149.
Crossref
Simonetta Stefanini, Emilia Chiancone, Stefano Cavallo, Victoria Saez, Adrian D. Hall & Robert C. Hider. (1991) The interaction of hydroxypyridinones with human serum transferrin and ovotransferrin. Journal of Inorganic Biochemistry 44:1, pages 27-37.
Crossref
GEORGE J. KONTOGHIORGHES. (1990) Design, Properties, and Effective Use of the Oral Chelator L1 and Other.. Annals of the New York Academy of Sciences 612:1 Sixth Cooley', pages 339-350.
Crossref
R. C. HIDER, S. SINGH, J. B. PORTER & E. R. HUEHNS. (1990) The Development of Hydroxypyridin-4-ones as Orally Active Iron Chelators. Annals of the New York Academy of Sciences 612:1 Sixth Cooley', pages 327-338.
Crossref
John Porter. (2009) Oral iron chelators: Prospects for future development. European Journal of Haematology 43:4, pages 271-285.
Crossref
. (1989) Oral Iron Chelators. The Lancet 334:8670, pages 1016-1017.
Crossref
J.B. Porter, K.P. Hoyes, R. Abeysinghe, E.R. Huehns & R.C. Hider. (1989) ANIMAL TOXICOLOGY OF IRON CHELATOR L1. The Lancet 334:8655, pages 156.
Crossref
J.B. Porter, E.R. Huehns & R.C. Hider. (1989) 2 The development of iron chelating drugs. Baillière's Clinical Haematology 2:2, pages 257-292.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.